This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Source-linked MATR3 Western blot protocol options, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-MATR3 WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, source-linked protocol options, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~94.6 kDa | |
| Observed band | ~125 kDa | |
| Gel | 5–20% (catalog A02931-2) | |
| Positive control | Adipose tissue (IHC candidate; verify WB) +4 more | |
| Negative control | Suggested KO / knockdown lysate |
| PTM | Phosphorylated + Acetylated | |
| Caveat | Phosphorylation-state controls | |
| Gene-set association | MSigDB C7 membership | |
| Isoform | 2 isoform(s) |
The A02931-2 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | human MCF-7, human SH-SY5Y, human RT4, human HepG2, rat brain, mouse brain (catalog A02931-2) |
| Gel % | 5–20% (catalog A02931-2) |
| Load | 30 ug; reducing conditions (catalog A02931-2) |
| Transfer | a nitrocellulose membrane at 150 mA for 50-90 minutes (catalog A02931-2) |
| Membrane | nitrocellulose membrane (catalog A02931-2) |
| Blocking | 5% non-fat milk/TBS for 1.5 hour at RT (catalog A02931-2) |
| Primary antibody | A02931-2 · 0.25 μg/mL (catalog A02931-2) |
| Primary incubation | overnight at 4°C (catalog A02931-2) |
| Secondary antibody | goat anti-rabbit IgG-HRP, 1:5000 (catalog A02931-2) |
| Secondary incubation | 1.5 hour at RT (catalog A02931-2) |
| Wash | TBS-0.1%Tween 3 times with 5 minutes each (catalog A02931-2) |
| Detection | ECL (catalog A02931-2) |
MATR3 is predicted at 94.6 kDa but observed at approximately 125 kDa; the cause of this difference is not established by the supplied evidence.
| Band near 125 kDa | Matches the empirical MATR3 band; confirm identity with antibody controls |
| Band near 95 kDa | Near the 94.6 kDa predicted mass; identity requires confirmation |
| Several discrete bands | Isoforms 1 and 2 are possible contributors, but distinct migration is unproven |
| Stronger band in a nuclear matrix fraction | Consistent with MATR3 localization to the nuclear matrix |
| UniProt predicted mass | 94.6 kDa is the sequence-based mass; the empirical band is approximately 125 kDa, with no established cause for the difference |
| Isoform 1 | Its individual mass and migration are not supplied |
| Isoform 2 | Its individual mass and migration are not supplied |
| Alternative splicing of isoforms 1 and 2 | Could affect band size, but distinct band positions are not established |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | Nuclear matrix MATR3 may be poorly recovered | Check nuclear matrix extraction and a positive lysate |
| Band higher than expected | The empirical MATR3 band is approximately 125 kDa despite a 94.6 kDa predicted mass; the cause is unestablished | Compare with the QC band and confirm identity with an independent antibody |
| Band lower than expected | An isoform or degradation is possible, but its identity is unestablished | Check sample integrity and confirm identity with an independent antibody |
| Multiple bands | Isoforms 1 and 2 or nonspecific binding are possible | Compare independent antibodies and check which bands track with MATR3 depletion |
| Weak or no signal | Nuclear matrix MATR3 may be poorly extracted | Verify extraction and enrich the nuclear matrix fraction |
| Fragments below expected size | Sample degradation is possible; no fragment masses are supplied | Check sample handling and compare fresh lysate with independent antibody detection |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Adipose tissue | adipocytes | High | Protein (IHC) | HPA → |
| Adrenal gland | glandular cells | High | Protein (IHC) | HPA → |
| Appendix | glandular cells | High | Protein (IHC) | HPA → |
| Bone marrow | hematopoietic cells | High | Protein (IHC) | HPA → |
| Breast | adipocytes | High | Protein (IHC) | HPA → |
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Spleen | cells in red pulp | Medium | Protein (IHC) | HPA → |
| Adipose tissue | adipocytes | High | Protein (IHC) | HPA → |
| Adrenal gland | glandular cells | High | Protein (IHC) | HPA → |
| Appendix | glandular cells | High | Protein (IHC) | HPA → |
| Bone marrow | hematopoietic cells | High | Protein (IHC) | HPA → |
Deeper troubleshooting and optimisation questions for MATR3, answered from its protein features.
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
The catalog reports one anti-MATR3 antibody, A02931-2, with reported human, mouse, and rat reactivity. Its Western blot image uses human cell and rat and mouse brain lysates; the reported band is approximately 125 kDa, versus an expected 95 kDa.
Which to pick: A02931-2 is the only listed option and has a Western blot image. Its caption documents human MCF-7, SH-SY5Y, RT4, and HepG2 cell lysates plus rat and mouse brain lysates, using antibody at 0.25 μg/mL.